171 related articles for article (PubMed ID: 30165526)
1. Marburg Virus Viral Protein 35 Inhibits Protein Kinase R Activation in a Cell Type-Specific Manner.
Hume A; Mühlberger E
J Infect Dis; 2018 Nov; 218(suppl_5):S403-S408. PubMed ID: 30165526
[TBL] [Abstract][Full Text] [Related]
2. Impact of Měnglà Virus Proteins on Human and Bat Innate Immune Pathways.
Williams CG; Gibbons JS; Keiffer TR; Luthra P; Edwards MR; Basler CF
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295912
[TBL] [Abstract][Full Text] [Related]
3. Innate Immune Responses of Bat and Human Cells to Filoviruses: Commonalities and Distinctions.
Kuzmin IV; Schwarz TM; Ilinykh PA; Jordan I; Ksiazek TG; Sachidanandam R; Basler CF; Bukreyev A
J Virol; 2017 Apr; 91(8):. PubMed ID: 28122983
[TBL] [Abstract][Full Text] [Related]
4. Lloviu virus VP24 and VP35 proteins function as innate immune antagonists in human and bat cells.
Feagins AR; Basler CF
Virology; 2015 Nov; 485():145-52. PubMed ID: 26255028
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for Marburg virus VP35-mediated immune evasion mechanisms.
Ramanan P; Edwards MR; Shabman RS; Leung DW; Endlich-Frazier AC; Borek DM; Otwinowski Z; Liu G; Huh J; Basler CF; Amarasinghe GK
Proc Natl Acad Sci U S A; 2012 Dec; 109(50):20661-6. PubMed ID: 23185024
[TBL] [Abstract][Full Text] [Related]
6. Recombinant Marburg viruses containing mutations in the IID region of VP35 prevent inhibition of Host immune responses.
Albariño CG; Wiggleton Guerrero L; Spengler JR; Uebelhoer LS; Chakrabarti AK; Nichol ST; Towner JS
Virology; 2015 Feb; 476():85-91. PubMed ID: 25531184
[TBL] [Abstract][Full Text] [Related]
7. Evasion of interferon responses by Ebola and Marburg viruses.
Basler CF; Amarasinghe GK
J Interferon Cytokine Res; 2009 Sep; 29(9):511-20. PubMed ID: 19694547
[TBL] [Abstract][Full Text] [Related]
8. Effects of Filovirus Interferon Antagonists on Responses of Human Monocyte-Derived Dendritic Cells to RNA Virus Infection.
Yen BC; Basler CF
J Virol; 2016 May; 90(10):5108-5118. PubMed ID: 26962215
[TBL] [Abstract][Full Text] [Related]
9. Marburg virus VP35 can both fully coat the backbone and cap the ends of dsRNA for interferon antagonism.
Bale S; Julien JP; Bornholdt ZA; Kimberlin CR; Halfmann P; Zandonatti MA; Kunert J; Kroon GJ; Kawaoka Y; MacRae IJ; Wilson IA; Saphire EO
PLoS Pathog; 2012 Sep; 8(9):e1002916. PubMed ID: 23028316
[TBL] [Abstract][Full Text] [Related]
10. Crystal Structure of the Marburg Virus Nucleoprotein Core Domain Chaperoned by a VP35 Peptide Reveals a Conserved Drug Target for Filovirus.
Zhu T; Song H; Peng R; Shi Y; Qi J; Gao GF
J Virol; 2017 Sep; 91(18):. PubMed ID: 28659479
[TBL] [Abstract][Full Text] [Related]
11. Crystal Structure of the Marburg Virus VP35 Oligomerization Domain.
Bruhn JF; Kirchdoerfer RN; Urata SM; Li S; Tickle IJ; Bricogne G; Saphire EO
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847355
[TBL] [Abstract][Full Text] [Related]
12. Rousette Bat Dendritic Cells Overcome Marburg Virus-Mediated Antiviral Responses by Upregulation of Interferon-Related Genes While Downregulating Proinflammatory Disease Mediators.
Prescott J; Guito JC; Spengler JR; Arnold CE; Schuh AJ; Amman BR; Sealy TK; Guerrero LW; Palacios GF; Sanchez-Lockhart M; Albariño CG; Towner JS
mSphere; 2019 Dec; 4(6):. PubMed ID: 31801842
[TBL] [Abstract][Full Text] [Related]
13. Structural Insight into Nucleoprotein Conformation Change Chaperoned by VP35 Peptide in Marburg Virus.
Liu B; Dong S; Li G; Wang W; Liu X; Wang Y; Yang C; Rao Z; Guo Y
J Virol; 2017 Aug; 91(16):. PubMed ID: 28566377
[TBL] [Abstract][Full Text] [Related]
14. Differential Regulation of Interferon Responses by Ebola and Marburg Virus VP35 Proteins.
Edwards MR; Liu G; Mire CE; Sureshchandra S; Luthra P; Yen B; Shabman RS; Leung DW; Messaoudi I; Geisbert TW; Amarasinghe GK; Basler CF
Cell Rep; 2016 Feb; 14(7):1632-1640. PubMed ID: 26876165
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylated VP30 of Marburg Virus Is a Repressor of Transcription.
Tigabu B; Ramanathan P; Ivanov A; Lin X; Ilinykh PA; Parry CS; Freiberg AN; Nekhai S; Bukreyev A
J Virol; 2018 Nov; 92(21):. PubMed ID: 30135121
[TBL] [Abstract][Full Text] [Related]
16. Marburg virus evades interferon responses by a mechanism distinct from ebola virus.
Valmas C; Grosch MN; Schümann M; Olejnik J; Martinez O; Best SM; Krähling V; Basler CF; Mühlberger E
PLoS Pathog; 2010 Jan; 6(1):e1000721. PubMed ID: 20084112
[TBL] [Abstract][Full Text] [Related]
17. Novel activities by ebolavirus and marburgvirus interferon antagonists revealed using a standardized in vitro reporter system.
Guito JC; Albariño CG; Chakrabarti AK; Towner JS
Virology; 2017 Jan; 501():147-165. PubMed ID: 27930961
[TBL] [Abstract][Full Text] [Related]
18. Filoviral immune evasion mechanisms.
Ramanan P; Shabman RS; Brown CS; Amarasinghe GK; Basler CF; Leung DW
Viruses; 2011 Sep; 3(9):1634-49. PubMed ID: 21994800
[TBL] [Abstract][Full Text] [Related]
19. The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR.
Feng Z; Cerveny M; Yan Z; He B
J Virol; 2007 Jan; 81(1):182-92. PubMed ID: 17065211
[TBL] [Abstract][Full Text] [Related]
20. The Ebola virus VP35 protein binds viral immunostimulatory and host RNAs identified through deep sequencing.
Dilley KA; Voorhies AA; Luthra P; Puri V; Stockwell TB; Lorenzi H; Basler CF; Shabman RS
PLoS One; 2017; 12(6):e0178717. PubMed ID: 28636653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]